Nanomedicine News

RSS

Tracking Delivery of Therapeutic Nanoparticle to Breast Tumor

Researchers at Rice University, collaborating with investigators at the Baylor College of Medicine, have used two different types of imaging technologies to track the delivery of a therapeutic nanoparticle to breast tumo...

17 Dec 2010

Microsensor to Answer One of the Weightiest Questions in Biology

Researchers at the University of Illinois, Urbana-Champaign, have developed a new kind of microsensor to answer one of the weightiest questions in biology – the relationship between cell mass and growth rate. The team, led by Rashid Bashir, published its results in the Proceedings of the National Academy of Sciences.

17 Dec 2010

Research Team Creates "Nanobioconjugate" Drug to Target Brain Tumors

Nine years ago, scientists at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute detected a subtle shift occurring in the molecular makeup of the most aggressive type of brain tumors, glioblastoma multiforme. With ...

17 Dec 2010

Geometrical Confinement of Gadolinium-Based Contrast Agents in Nanoporous Particles Enhances T1 Contrast

A porous, disk-shaped "nest" for nanotubes may help magnetic resonance imaging become better than ever at finding evidence of cancer if the results of research led by investigators at Rice University are any in...

17 Dec 2010

NanoLogix Conducts GBS Quick-Tests at University of Texas Health Science Center

NanoLogix an innovator in the accelerated detection and identification of microorganisms, announces the current 300 patient trial of NanoLogix GBS (Group B Streptococcus) Quick Tests is ongoing at the University of Texas Health Science Center (UTHSC) in Houston.

From NanoLogix 14 Dec 2010

Access Pharmaceuticals to Provide Nano-Based Drug Delivery Technology to Global Pharma Company

ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, ann...

From Abeona Therapeutics Inc. 13 Dec 2010

Cerulean Pharma to Showcase Nanopharmaceutical Platform at Nanotechnology Innovation Summit

Cerulean Pharma Inc., a leader in designing and developing nanopharmaceuticals, today announced that Alexandra Glucksmann, Ph.D., the Company’s Senior Vice President, Research and Business Operations, will present at the Nanotechnology Innovation Summit being organized by the Nano Science and Technology Institute (NSTI) in celebration of the 10th anniversary of the National Nanotechnology Initiative (NNI). The Summit is being held in Washington, D.C., from December 8-10, 2010.

From Cerulean Pharma 10 Dec 2010

Unidym Signs Contract with Samsung to Manufacture Carbon Nanotubes

Arrowhead Research Corporation’s (“the Company”) President and Chief Executive Officer today issued the following open letter to the Company’s shareholders:

From Arrowhead Pharmaceutical 10 Dec 2010

MonoSol Partners with Midatech to Accelerate Nanoinsulin PharmFilm Development

MonoSol Rx, the developer of PharmFilm® drug delivery technology, and Midatech Group Ltd., a global leader and centre of excellence for the design, development, synthesis and manufacture of nanomedicines, today announced their intent to form a joint venture that will focus on the development and commercialization of products combining the two companies' respective technologies in the diabetes field.

9 Dec 2010

enGene's CSO to Discuss Nanoparticle Gene Delivery System for Colitis Treatment

enGene Inc., a privately held biotechnology company developing an innovative platform technology to deliver nucleotides (DNA or siRNA) to mucosal tissue for treating a variety of diseases, announced today that Dr. Anthon...

9 Dec 2010